Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
DDX3Y
REST API REST API
Homo sapiens
DDX3Y is differentially expressed in 302 experiments: 84 organism parts: ovary, testis, ... (82 more);, 151 disease states: normal, Burkitt's lymphoma, ... (149 more);, 79 cell types 549 cell lines 44 compound treatments and 71 other conditions.
Synonyms DBY
Orthologs pl10 (Danio rerio)   DBP1 (Saccharomyces cerevisiae)   F1NIX1_CHICK (Gallus gallus)   ddx3 (Danio rerio)   Ddx3y (Mus musculus)   DED1 (Saccharomyces cerevisiae)   F6WIK1_CIOIN (Ciona intestinalis)   ddx3x (Xenopus laevis)   D3IVZ2_BOVIN (Bos taurus)   bel (Drosophila melanogaster)   (Compare orthologs)
Gene Ontology Term DNA binding, cytoplasm, ATP-dependent helicase activity, nucleic acid binding, ATP binding, nucleus, nucleotide binding, hydrolase activity, RNA binding, helicase activity
InterPro Term DNA/RNA_helicase_DEAD/DEAH_N, RNA_helicase_DEAD_Q_motif, Helicase_C, DEAD-like_helicase
UniProt Accession O15523, C9J081, C9J8G5, B4DXX7
Search EB-eye ENSG00000067048
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-6573, E-MTAB-24, E-MEXP-433, E-MTAB-25, ... (23 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, ... (46 experiments)

Factor Value U/D Experiments
SW480
3
E-MEXP-1014, E-MTAB-37, E-GEOD-18005
A549
2
E-GEOD-3202, E-GEOD-6013
DU145
2
E-GEOD-20089, E-GEOD-17482
HL-60
2
E-GEOD-24147, E-MTAB-37
Jurkat
2
E-GEOD-1880, E-MEXP-2197
MOLT4
2
E-MTAB-62, E-MTAB-37
543 more value(s).


Cell type

studied in E-GEOD-492, E-GEOD-22373, E-GEOD-3920, E-MEXP-66, E-GEOD-20677, ... (39 experiments)

Factor Value U/D Experiments
mononuclear cell
3
E-GEOD-6053, E-GEOD-7307, E-MEXP-66
721 B lymphoblast
2
E-AFMX-5, E-TABM-145
CD34+
2
E-AFMX-5, E-TABM-145
human embryonic stem cell
2
E-GEOD-18147, E-GEOD-18265
testis - leydig cell
2
E-AFMX-5, E-TABM-145
whole blood
2
E-GEOD-3026, E-MTAB-25
73 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-MEXP-25, E-GEOD-15960, E-MEXP-2069, ... (46 experiments)

Factor Value U/D Experiments
colon carcinoma
3
E-MTAB-37, E-GEOD-3726, E-MTAB-62
prostate carcinoma
3
E-MEXP-2034, E-MTAB-62, E-GEOD-7307
uterine fibroid
2
E-GEOD-7307, E-MTAB-62
cervical carcinoma
1
2
E-MTAB-62, E-MEXP-1331, E-MTAB-37
Burkitt's lymphoma
1
2
E-MTAB-37, E-GEOD-1880, E-GEOD-96
acute myelomonocytic leukemia
1
E-MTAB-62
145 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-6907, E-GEOD-5741, E-GEOD-15205, E-TABM-782, ... (24 experiments)

Factor Value U/D Experiments
none
2
5
E-TABM-782, E-MEXP-1958, E-GEOD-2803, E-GEOD-412, E-GEOD-995, ... (7 experiments)
lipopolysaccharide
1
2
E-MEXP-1958, E-GEOD-3982, E-TABM-868
baseline sevoflurane
1
E-GEOD-4386
2-(3,4,5-trimethoxy-phenylamino)-pyrrolo[2,3-d]pyrimidines
1
1
E-GEOD-6932
glucose
1
E-MEXP-941
glutamine
1
E-MEXP-941
38 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
71
2
1
E-GEOD-21653
48
2
1
E-GEOD-21653
38
2
1
E-GEOD-21653


Age years
studied in E-TABM-783

Agent
studied in E-GEOD-19519

Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, ... (9 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-5372, E-GEOD-20499, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-MEXP-2359, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-TABM-147, E-GEOD-2280

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-6207, E-GEOD-17385, E-GEOD-20847, E-MTAB-108, E-MEXP-563 ... (5 experiments)

Genotype
studied in E-GEOD-1923, E-MEXP-149, E-GEOD-17476, E-MEXP-421, E-TABM-868, ... (9 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-TABM-127, E-GEOD-20540, E-GEOD-10315, ... (6 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-GEOD-1926, E-GEOD-3720, E-GEOD-10433, E-TABM-118, E-GEOD-16363, ... (52 experiments)

Infection
studied in E-GEOD-9723, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-7179

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-2634, E-GEOD-7540, E-AFMX-1, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-1493, E-GEOD-22309, E-GEOD-21750

Population
studied in E-MTAB-197

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246

Qrt pcr areg dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-15811, E-GEOD-18791

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-MEXP-548

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70

Sex
studied in E-GEOD-22097, E-GEOD-20153, E-GEOD-2466, E-GEOD-7540, E-TABM-118, ... (56 experiments)

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

tissue (organ)
studied in E-GEOD-22601

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-19246

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Processing time: 0.459 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM